These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37349083)

  • 1. Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
    Scherbak NN; Kruse R; Nyström T; Jendle J
    Diabetes Metab J; 2023 Sep; 47(5):668-681. PubMed ID: 37349083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81).
    Scherbak NN; Kruse R; Nyström T; Jendle J
    Diabetes Metab J; 2023 Nov; 47(6):882-883. PubMed ID: 38043784
    [No Abstract]   [Full Text] [Related]  

  • 3. Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81).
    Lee DY
    Diabetes Metab J; 2023 Nov; 47(6):879-881. PubMed ID: 38043783
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride.
    Jendle J; Hyötyläinen T; Orešič M; Nyström T
    Cardiovasc Diabetol; 2021 Dec; 20(1):237. PubMed ID: 34920733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study.
    Eyileten C; Wicik Z; Keshwani D; Aziz F; Aberer F; Pferschy PN; Tripolt NJ; Sourij C; Prietl B; Prüller F; von Lewinski D; De Rosa S; Siller-Matula JM; Postula M; Sourij H
    Cardiovasc Diabetol; 2022 May; 21(1):79. PubMed ID: 35596173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.
    Ortega FJ; Mercader JM; Moreno-Navarrete JM; Rovira O; Guerra E; Esteve E; Xifra G; Martínez C; Ricart W; Rieusset J; Rome S; Karczewska-Kupczewska M; Straczkowski M; Fernández-Real JM
    Diabetes Care; 2014; 37(5):1375-83. PubMed ID: 24478399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating early- and mid-pregnancy microRNAs and risk of gestational diabetes.
    Wander PL; Boyko EJ; Hevner K; Parikh VJ; Tadesse MG; Sorensen TK; Williams MA; Enquobahrie DA
    Diabetes Res Clin Pract; 2017 Oct; 132():1-9. PubMed ID: 28783527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes induces dysregulation of microRNAs associated with survival, proliferation and self-renewal in cardiac progenitor cells.
    Purvis N; Kumari S; Chandrasekera D; Bellae Papannarao J; Gandhi S; van Hout I; Coffey S; Bunton R; Sugunesegran R; Parry D; Davis P; Williams MJA; Bahn A; Katare R
    Diabetologia; 2021 Jun; 64(6):1422-1435. PubMed ID: 33655378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the pathogenesis of type 2 diabetes mellitus intestinal damp-heat syndrome and the therapeutic effect of Gegen Qinlian Decoction from the perspective of exosomal miRNA.
    He L; Bao T; Yang Y; Wang H; Gu C; Chen J; Zhai T; He X; Wu M; Zhao L; Tong X
    J Ethnopharmacol; 2022 Mar; 285():114786. PubMed ID: 34763043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miRNAs in Type 2 Diabetic Patients with and without Albuminuria in Malaysia.
    Zahari Sham SY; Ng CT; Azwar S; Yip WK; Abdullah M; Thevandran K; Osman M; Seow HF
    Kidney Blood Press Res; 2022; 47(2):81-93. PubMed ID: 35158353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitus.
    Sullivan SD; Alfonso-Cristancho R; Conner C; Hammer M; Blonde L
    Pharmacotherapy; 2009 Nov; 29(11):1280-8. PubMed ID: 19873688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside.
    Grieco GE; Besharat ZM; Licata G; Fignani D; Brusco N; Nigi L; Formichi C; Po A; Sabato C; Dardano A; Natali A; Dotta F; Sebastiani G; Ferretti E
    Transl Res; 2022 Sep; 247():137-157. PubMed ID: 35351622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression Profiles of Circulating microRNAs in South African Type 2 Diabetic Individuals on Treatment.
    Weale CJ; Matshazi DM; Davids SFG; Raghubeer S; Erasmus RT; Kengne AP; Davison GM; Matsha TE
    Front Genet; 2021; 12():702410. PubMed ID: 34567065
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients.
    Mahjoob G; Ahmadi Y; Fatima Rajani H; Khanbabaei N; Abolhasani S
    J Clin Lab Anal; 2022 May; 36(5):e24380. PubMed ID: 35349731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating MiRNAs of 'Asian Indian Phenotype' Identified in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes.
    Prabu P; Rome S; Sathishkumar C; Aravind S; Mahalingam B; Shanthirani CS; Gastebois C; Villard A; Mohan V; Balasubramanyam M
    PLoS One; 2015; 10(5):e0128372. PubMed ID: 26020947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US.
    Lee WC; Conner C; Hammer M
    Curr Med Res Opin; 2011 May; 27(5):897-906. PubMed ID: 21348806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Profiling of Targeted miRNAs (8-nt) for the Genes Involved in Type 2 Diabetes Mellitus and Cardiac Hypertrophy].
    Hussain K; Ishtiaq A; Mushtaq I; Murtaza I
    Mol Biol (Mosk); 2023; 57(2):360-361. PubMed ID: 37000663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating serum microRNAs including senescent miR-31-5p are associated with incident fragility fractures in older postmenopausal women with type 2 diabetes mellitus.
    Heilmeier U; Hackl M; Schroeder F; Torabi S; Kapoor P; Vierlinger K; Eiriksdottir G; Gudmundsson EF; Harris TB; Gudnason V; Link TM; Grillari J; Schwartz AV
    Bone; 2022 May; 158():116308. PubMed ID: 35066213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.